The role of heme oxygenase-1 in T cell-mediated immunity: The all encompassing enzyme

Current Pharmaceutical Design

Volumn 14, Issue 5, 2008, Pages 454-464

  Xia, Z W ^a,b,c   Zhong, W W ^a,b,c   Meyrowitz, J S ^a,b,c   Zhang, Z L ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Heme oxygenase 1; Immunity; T cells

Indexed keywords

BILIVERDIN; CD4 ANTIBODY; GLUCOCORTICOID; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 17; INTERLEUKIN 6; PROTOPORPHYRIN COBALT;

ALLERGIC ASTHMA; ALLERGIC DISEASE; APOPTOSIS; ASTHMA; ATOPIC DERMATITIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; GRAFT REJECTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; HEME OXYGENASE-1; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, CELLULAR; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 42049110786     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783597326     Document Type: Review

References (193)

1. Weng YH, Yang G, Weiss S, Dennery PA. Interaction between heme oxygenase-1 and -2 proteins. J Biol Chem 2003; 278: 50999-1005.
2. Scapagnini G, D'Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, et al. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 2002; 954: 51-9.
3. McCoubrey WK Jr, Huang TJ, Maines M. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247: 725-32.
4. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 2004; 336: 241-50.
5. Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1132-42.
6. Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, Bauer AJ. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 2006; 290: 695-703.
7. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005; 202: 1763-13.
8. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-8.
9. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 2002; 2: 739-45.
10. Takamiya R, Murakami M, Kajimura M, Goda N, Makino N, Takamiya Y, et al. Stabilization of mast cells by Hemin oxygenase-1: An anti-inflammatory role. Am J Physiol Heart Circ Physiol 2002; 283: H861-70.
11. Ryter SW, Choi AM. Heme oxygenase-1: Redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 2005; 7: 80-91.
12. Wunder C, Potter RF. The heme oxygenase system: Its role in liver inflammation. Curr Drug Targets Cardiovasc Haematol Disord 2003; 3: 199-558.
13. Ke B, Shen XD, Buelow R, Melinek J, Amersi F, Gao F, et al. Heme oxygenase-1 gene transfer prevents CD95/FasL-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Transplant Proc 2002; 34: 1465-6.
14. Kushida T, LiVolti G, Goodman AI, Abraham NG. TNF-alpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant Proc 2002; 34: 2973-8.
15. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001; 7: 693-8.
16. Song R, Mahidhara RS, Liu F, Ning W, Otterbein LE, Choi AM. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol 2002; 27: 603-10.
17. Jia YX, Sekizawa K, Okinaga S, Lie R, Sasaki H. Role of heme oxygenase in pulmonary response to antigen challenge in sensitized rats in vivo. Int Arch Allergy Immunol 1999, 120: 141-5.
18. Almolki A, Talllé C, Martin GF, Jose PJ, Zedda C, Conti M, et al. Hemin oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol 2004; 287: L26-34.
19. Chapman JT, Otterbein LE, Elias JA, Choi AM. Carbon monoxide attenuates aeroallergen-ioduced inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2001; 281: L209-16.
20. Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, et al. Heme oxygenast-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001; 1: 121-8.
21. Schnickel GT, Hsieh GR, Kachikwu EL, Garcia C, Shefizade A, Fishbein MC, et al. Cytoprotective gene HO-1 and chronic rejection in heart transplantation. Transplant Proc 2006; 38: 3259-62.
22. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001; 166: 4185-94.
23. Tsui TY, Wu X, Lau CK, Ho DW, Xu T, Siu YT, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623-9.
24. Wang XH, Wang K, Zhang F, Li XC, Li J, De W, Guo J, Qian XF, Fan Y. Heme oxygenase-1 alleviates ischemia/reperfusion injury in aged liver. World J Gastroenterol 2005; 11: 690-4
25. Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: A new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 Suppl 1: 177-84.
26. Varga C, Laszlo F, Fritz P, Cavicchi M, Lamarque D, Horvath K, et al. Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat. Eur J Pharmacol 2007; 561: 164-71.
27. Giriş M, Erbil Y, Doǧru-Abbasoǧlu S, Yanik BT, Aliş H, Olgaç V, et al. The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. The effect of glutamine on TNBS colitis. Int J Colorectal Dis 2007; 22: 591-9.
28. Berberat PO, A-Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, et al. Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm Bowel Dis 2005; 11: 350-9.
29. Dijkstra G, Blokzijl H, Bok L, Homan M, van Goor H, Faber KN, et al. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J Pathol 2004; 204: 296-303.
30. Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS. Heme oxygenase-1 plays an important protective role in experimental auto-immune encephalomyelitis. Neuroreport 2001; 12: 1841-5.
31. Emerson MR, LeVine SM. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: An expanded view of the stress response. J Neurochem 2000; 75: 2555-62.
32. McGee HS, Agrawal DK. TH2 cells in die pathogenesis of airway remodeling: Regulatory T cells a plausible panacea for asthma. Immunol Res 2006, 35: 219-32.
33. Effros RM, Nagaraj H. Asthma: New developments concerning immune mechanisms, diagnosis and treatment. Curr Opin Pulm Med 2007; 13: 37-43.
34. Niederkorn JY. Immunology and immunomodulation of corneal transplantation. Int Rev Immunol 2002; 21: 173-96.
35. Marques VP, Gongalves GM, Feitoza CQ, Cenedeze MA, Fernandes Bertocchi AP, Damião MJ, et al. Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion, injury. Nephron Exp Nephrol 2006; 104: E48-56.
36. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J Immunol 2007; 178: 8138-47.
37. Bamias G, Cominelli F. Immunopathogenesis of inflammatory bowel disease: current concepts. Curr Opin Gastroenterol 2007; 23: 365-9.
38. Baumgart DC, Carding SR. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007; 369: 1627-40.
39. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Sarma JD, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 3268-75.
40. Furuzawa CJ, Vargas RMI, Cabral AR. Autommume inflammation from the Th17 perspective. Autoimun Rev 2007; 6: 169-75.
41. Reiner SL. Development in motion: Helper T cells at work. Cell 2007; 129: 33-6.
42. Toh ML, Miossec P. The role of T cells in rheumatoid arthritis: New subsets and new targets. Curr Opin Rheumatol 2007; 19: 284-8.
43. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19: 281-6.
44. Kramer JM, Gaffen SL. Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007; 78: 1083-93.
45. Rouse BT. Regulatory T cells in health and disease. J Intern Med 2007; 262: 78-95.
46. Long ET, Wood KJ. Regulatory T cells - a journey from rodents to the clinic. Front Biosci 2007; 12: 4042-9.
47. Fontenot JD, Rudensky AY. Molecular aspects of regulatory T cell development. Semin Immunol 2004; 16: 73-80.
48. Jonuleit H, Schmitt E. The regulatory T cell family: Distinct subsets and their interrelations. J Immunol 2003; 171: 6323-7.
49. Lan RY, Ansari AA, Lian ZX, Gershwin ME. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005; 4: 351-63.
50. Roncarolo MG, Gregori S, Levings M. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 2003; 252: 115-27.
51. Santana, MA, Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 2003; 195: 392-401.
52. Pae HO, Choi BM, Oh GS, Lee MS, Ryu DG, Rhew HY, et al. Roles of heme oxygenase-1 in the antiproliferative and antiapoptotic effects of nitric oxide on Jurkat T cells. Mol Pharmacol 2004; 66: 122-8.
53. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172: 4744-51.
54. Song R, Zhou Z. Kim PK, Shapiro RA, Liu F, Ferran C, et al. Carbon monoxide promotes Fas/CD95 -induced apoptosis in Jurkat cells. J Biol Chem 2004; 279: 44327-34.
55. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, Flavell RA, et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172: 1220-6.
56. Wilhelm S, Wagner H, Hacker G. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur J Immunol 1998; 28: 891-900.
57. Misra RS, Russell JQ, Koenig A, Hinshaw-Makepeace JA, Wen R, Wang D, et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem 2007; 282: 19365-74.
58. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007; 7: 532-42.
59. Lakhani S, Flavell RA. Caspases and T lymphocytes: A flip of the coin? Immunol Rev 2003; 193: 22-30.
60. Amrani A, Verdaguer J, Serra P, Tafuro, S, Tan R, Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000; 406: 739-42.
61. Yang YG, Sykes M. Xenotransplantation: Current status and a perspective on the future. Nat Rev Immunol 2007; 7: 519-31.
62. Cozzi E, Bosio E, Seveso M, Vadori M, Ancona E. Xenotransplantation-current status and future perspectives. Br Med Bull 2006; 75-76: 99-114.
63. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503-9.
64. Matzinger, P. The danger model: A renewed sense of self. Science 2002; 296, 301-5.
65. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491-6.
66. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh MH. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/ reperfusion injury. Kidney Int 1997; 52: 1678-84.
67. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199-203.
68. De Greef KE, Ysebaert DK, Dauwe S, Persy V, Vercauteren SR, Mey D, et al. Anti-B7-f blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60: 1415-27.
69. Burne-Taney MJ, Yokota-Ikeda N, Rabb H. Effects of combined T-and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant 2005; 5: 1186-93.
70. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 109: 1283-90.
71. Yokota N, Daniels F, Crosson J, Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplant 2002; 74:759-63.
72. Yokota N, Bume-Taney M, Racusen L, Rabb H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003; 285: F319-25.
73. Kato A, Graul-Layman A, Edwards MJ, Lentsch AB. Promotion of hepatic ischemia/reperfusion injury by IL-12 is independent of STAT4. Transplant 2002; 73: 1142-5.
74. Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-7.
75. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003; 93: 70-81.
76. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fasmediated apoptosis. J Immunol 1999; 162: 5205-11.
77. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8: 615-23.
78. Van PL, Biuckians A, Abbas AK. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J Immunol 1998; 160: 2065-71.
79. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-8.
80. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781-828.
81. Ewing P, Hildebran GC, Planke S, Andreesen R, Holler E, Gerbitz A. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation. Int J Mol Med 2007; 20: 301-8.
82. Wasserberg N, Pileggi A, Salgar SK, Ruiz P, Ricordi C, Inverardi L, et al. Heme oxygenase-1 upregulation protects against intestinal ischemia/reperfusion injury: A laboratory based study. Int J Surg 2007; 5: 216-24.
83. Soares MP, Bach FH. Heme oxygenase-1 in organ transplantation. Front Biosci 2007; 12: 4932-45.
84. Schnickel GT, Hsieh GR, Kachikwu EL, Garcia C, Shefizadeh A, Fishbein MC, et al. Cytoprotective gene HO-1 and chronic rejection in heart transplantation. Transplant Proc 2006; 38: 3259-62.
85. Xia ZW, Sun JL, Qi Q, Zhong WW, Zhang XH, Zhang ZL. Heme oxygenase-1 improves the survival of discordant cardiac xenograft through its anti-inflammatory and anti-apoptotic effects. Pediatr Transplantat 2007 (Published article online: 10-May-2007).
86. Wang XH, Wang K, Zhang F, Li XC, Qian XF, Cheng F, et al. Alleviating ischemia-reperfusion injury in aged rat liver by induction of heme oxygenase-1. Transplant Proc 2004; 36: 2917-23.
87. Li Y, Li G, Dong W, Chen J, Lu D, Tan J. Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector. Pancreas 2006; 33: 280-6.
88. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, et al. Carbon Monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-26.
89. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006; 10: 650-71.
90. Yamashita K, McDaid J, Ollinger R, Tsui TY, Berberat PO, Usheva A, et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004; 18: 765-7.
91. Braudeau C, Bouchet D, Tesson L, Iyer S, Remy S, Buelow R, Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004; 11: 701-10.
92. Blydt-Hansen TD, Ka M, Lassman C, Ke B, Coito AJ, Iyer S, et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 745-54.
93. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-9.
94. Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau. C, Renaudin K, et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am. J. Transplant 2002; 2: 581-92
95. Araujo JA, Meng L, Tward AD, Hancock WW, Zhai Y, Lee A, et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 2003; 171: 1572-80.
96. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci 1997; 94: 10925-30.
97. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci 1997; 94: 10919-24.
98. McDaid J, Yamashita K, Chora A, Ollinger R, Strom TB, Li XC, et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J 2005; 19: 458-60.
99. Tsuchibashi S, Zhai Y, Bo Q, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: Inhibition of type-1 interferon signaling. Transplant 2007; 83: 1628-34.
100. Coito AJ, Shaw GD, Li J, Ke B, Ma J, Busuttil RW, et al. Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction in cardiac allograft recipients. Lab Invest 2002; 82: 61-70.
101. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in rnice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatol 2003; 37: 296-303.
102. Lee BS, Shim SM, Heo J, Pae HO, Seo BY, Han SY, et al. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression. J Dermatol Sci 2007; 46: 31-40
103. Bahceciler NN, Ozdemir C, Barlan IB. Immunologic aspects of sublingual immunotherapy in the treatment of allergy and asthma. Curr Med Chem 2007; 14: 265-9.
104. Agrawal DK, Bharadwaj A. Allergic airway inflammation. Curr Allergy Asthma Rep 2005; 5: 142-8.
105. Akbari O, Umetsu DT. Role of regulatory dendritic cells in allergy and asthma. Curr Opin Allergy Clin Immunol 2004; 4: 533-8.
106. Lo S, Di Palma S, Pitkin L, McCombe AW. Localisation of heme oxygenase isoforms in allergic human nasal mucosa. Eur Arch Otorhinolaryngol 2005; 262: 595-8.
107. Donnelly LE, Barnes PJ. Expression of heme oxygenase in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24: 295-303.
108. Yamaya M, Hosoda M, Ishizuka S, Monma M, Matsui T, Suzuki T, et al. Relation between exhaled carbon monoxide levels and clinical severity of asthma. Clin. Exp Allergy 2001; 31: 417-22.
109. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 2002; 166: S31-7.
110. Ohara Y, Ohrui T, Morikawa T, He M, Yasuda H, Yamaya M, et al. Exhaled carbon monoxide levels in school-age children with episodic asthma. Pediatr Pulmonol 2006; 41: 470-4.
111. Lim S, Groneberg D, Fischer A, Oates T, Caramori G, Mattos W, et al. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: Effect of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162: 1912-18.
112. Harju T, Soini Y, Pääkkö R, Kinnula VL. Up-regulation of heme oxygenase-1 in alveolar macrophages of newly diagnosed asthmatics. Respir Med 2002; 96: 418-23.
113. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, et al. Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 2006; 177: 5936-45.
114. Ameredes, BT, Otterbein LE, Kohut LK, Gligonic AL, Calhoun WJ, Choi AM. Low-dose carbon monoxide reduces airway hyper-responsiveness in mice, Am J Physiol Lung Cell Mol Physiol 2003; 285: L1270-6.
115. Ohrui T, Yasuda H, Yamaya M, Matsui T, Sasaki H. Transient relief of asthma symptoms during jaundice: A possible beneficial role of bilirubin. Tohoku J Exp Med 2003; 199: 193-6.
116. Yasui Y, Nakamura M, Onda T, Uehara T, Murata S, Matsui N, et al. Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem Biophys Res Commun 2007; 354: 485-90.
117. Listopad J, Asadullah K, Sievers C, Ritter T, Meisel C, Sabat R, et al. Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 2007; 16: 661-70.
118. Weaver CT, Harrington LE, Mangan PR, Gavrich M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-88.
119. DAenick EK, Tangye SG. Autoimmunity: IL-21: a new player in Th17-ce1I differentiation. Immunol Cell Biol 2007 (Epub ahead of print).
120. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation or pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-38
121. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-52.
122. Kastelein RO, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25: 221-42.
123. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-76.
124. Gaffen SL, Kramer JM, Yu JJ, Shen F. The IL-17 cytokine family. Vitam Horm 2006; 74: 255-82.
125. Laan M, Lötvall J, Chung KF, Lindén A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: Role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001; 133: 200-6.
126. Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 1999, 162:5337-44.
127. Lind A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy 2002; 57: 769-75.
128. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-32.
129. ParK H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-41.
130. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th 17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
131. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005; 171: 12-8.
132. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28: 42-50.
133. Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 2007; 7: 409-16.
134. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm, Bowel Dis 2006; 12: 382-8.
135. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004; 110: 55-62.
136. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006; 203: 2715-25.
137. Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, et al. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol 2005; 140: 547-55.
138. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 2007; 117: 438-47.
139. Ning W, Choi AM, Li C. Carbon monoxide inhibits IL-17-induced IL-6 production through the MAPK pathway in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005; 289: L268-73.
140. Bach FH. Carbon monoxide: From the origin of life to molecular medicine. Trends Mol Med 2006; 12: 348-50.
141. Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007; 37: 2396-99.
142. Lopes JE, Soper DM, Ziegler SF. Foxp3 is required throughout the life of a regulatory T cell. Sci STKE 2007; 2007: Pe36.
143. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor FoxP3. J Exp Med 2003; 98: 1875-86.
144. Ziegler SF. FOXP3: Of mice and men. Annu Rev Immunol 2006; 24: 209-26
145. Gambineri E, Torgerson T, Ochs H. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 5: 430-5.
146. Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterol 2007; 132: 1705-17.
147. Chang X, Gao JX, Jiang Q, Wen J, Seifers N, Su L, et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 2005; 202: 1141-51.
148. Le NT, Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007; 39: 1-9.
149. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol 2003; 4: 330-336.
150. Shevach EM. CD4+CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2005; 3: 331-41.
151. Prescott SL, Dunstan JA. Immune dysregulation in allergic respiratory disease: The role of T regulatory cells. Pulm Pharmacol Ther 2005; 18: 217-28.
152. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factorβ. J Exp Med 2001; 194: 629-44.
153. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-15.
154. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119: 1258-66.
155. Dao NX, Robinson DS. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 2004; 114: 296-301.
156. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Rückert B, et al. Glucocorticoids upregulate Foxp3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-33.
157. +T cells as well as transcription factor foxp3 in the dysregulation of allergic rhinitis. Laryngoscope 2007; 117: 876-80.
158. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autommiune diseases. J Immunol 1995; 155: 1151-64.
159. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387-96.
160. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-52.
161. Jiang S, Lechler RI, He XS, Huang JF. Regulatory T cells and transplantation tolerance. Hum Immunol 2006; 67: 765-76.
162. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641-6.
163. Heslan JM, Beriou G, Le Luduec JB, Guillonneau C, Anegon I, Soulillou JP, et al. Accumulation of T cells with potent regulatory properties and restricted Vbeta7-TCR rearrangements in tolerated allografts. Transplantation 2005; 80: 1476-84.
164. +T Regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 2006; 176: 7149-53.
165. Adeegbe D, Bayer AL, Levy RB, Malek TR. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652-62.
166. + regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053-9.
167. Giorgini A, Noble A. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. J Leukoc Biol 2007 (Epub ahead of print).
168. Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, et al. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+) CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery 2007; 142: 67-73.
169. Kang SM, Tang Q, Bluestone JA. CD4+CD25+ regulatory T cells in transplantation: Progress, challenges and prospects. Am J Transplant 2007; 7: 1457-63.
170. + T lymphocytes. Blood 2005; 105: 2090-2.
171. + T lymphocytes. Proc Natl Acad Sci 2005; 102: 11817-22.
172. Pae HO, Oh GS, Choi BM, Chae SC, Chung HT. Differential expressions of heme oxygenase-1 gene in CD25- and CD25+ subsets of human CD4+ T cells. Biochem Biophys Res Commun 2003; 306: 701-5
173. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
174. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003; 112:1437-43.
175. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of Heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327: 1066-71.
176. Xia ZW, Xu LQ, Zhong WW, Wei JJ, Li NL, Shao J, et al. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of Foxp3 T regulatory cells, IL-10 and membrane-bound TGF-β1. Am J Pathol 2007; 171: 1904-14.
177. Pearl JP, Xu H, Leopardi F, Preston E, Kirk AD. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. Transplant 2007; 83: 1219-25.
178. Jochum C, Beste M, Zellmer E, Graves SS, Storb R. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation. Biol Blood Marrow Transplant 2007; 13: 164-71.
179. Yamashita K, Ollinger R, McDaid J, Sakahama H, Wang H, Tyagi S, et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 2006; 20: 776-8.
180. Shen XD, Ke B, Zhai Y, Amersi F, Gao F, Anselmo DM, et al. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplant 2002; 74: 315-9.
181. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392-6.
182. Lee SS, Gao W, Mazzola S, Thomas MN, Csizmadia E, Otterbein LE, et al. Hemeoxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 2007 (Epub ahead of print).
183. Lin CC, Chiang LL, Lin CH, Shih CH, Liao YT, Hsu MJ, et al. Transforming growth factor-betal stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur J Pharmacol 2007; 560: 101-9.
184. Inoue S, Suzuki M, Nagashima Y, Suzuki, S, Hashiba T, Tsuburai T, et al. Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 2001; 12: 967-79.
185. Atzori L, Chua F, Dunsmore SE, Willis D, Barbarisi M, McAnulty RJ, et al. Attenuation of bleomycin induced pulmonary fibrosis in mice using the Heme oxygenase inhibitor Zndeuteroporphyrin IX-2,4-bisethylene glycol. Thorax 2004; 59: 217-23.
186. Reis e Sousa C.Dendritic cells in a mature age. Nat Rev Immunol 2006; 6: 476-83.
187. Bacchetta R, Gregori S, Roncarolo MG. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 2005; 4: 491-6.
188. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005; 105: 1162-9.
189. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-93.
190. Chauveau C, Rémy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005; 106: 1694-702.
191. Gonzalez-Rey E, Varela N, Chomy A, Delgado M. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator. Curr Pharm Des 2007; 13(11): 1113-39.
192. Iruretagoyen MI, Wiesendanger M, Kalergis AM. The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Curr Pharm Des 2006; 12(2): 131-47.
193. Karnes RJ, Whelan CM, Kwon ED. Immunotherapy for prostate cancer. Curr Pharm Des 2006; 12(7): 807-17.